Literature DB >> 28402398

The Health System and Policy Implications of Changing Epidemiology for Oral Cavity and Oropharyngeal Cancers in the United States From 1995 to 2016.

Charles W LeHew, Darien J Weatherspoon, Caryn E Peterson, Abigail Goben, Karolina Reitmajer, Herve Sroussi, Linda M Kaste.   

Abstract

Oral cavity and oropharyngeal cancers are typically grouped under the general term, "oral cancer." Yet, the incidence of oropharyngeal cancers is increasing in the United States, while the incidence of oral cavity cancers has declined. These 2 distinct but conflated groups of oral cancers are attributed to different risk factors. Incidence and survival trends were examined across US population groups and by anatomical subsite. Disparities in incidence and survival by sex, race/ethnicity, and subsite were identified. Risk factors are complex, interactive, and not fully identified. Cancer control research illustrates health disparities in access to care and patient outcomes. Database and supplemental searches yielded 433 articles published between 1995 and 2016 characterizing aspects of oral cancer epidemiology relating to incidence, survival, risk, disparities, and cancer control. Oral cavity cancer survival in black men remains the most intractable burden. Although understanding of oral cancer etiology is improving, application to policy is limited. Cancer control efforts are diverse, sporadic, limited in scope, and generally lacking in success, and they need stratification by oral cavity cancers/oropharyngeal cancers. Further intervention and epidemiologic research, improved workforce capacity, and integrated care delivery are identified as important directions for public health policy. Sustained, multilevel campaigns modeled on tobacco control success are suggested.
© The Author 2017. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  early detection of cancer; health-care disparities; incidence; mouth neoplasms; oropharyngeal neoplasms; risk behavior; survival; α-papillomavirus

Mesh:

Year:  2017        PMID: 28402398     DOI: 10.1093/epirev/mxw001

Source DB:  PubMed          Journal:  Epidemiol Rev        ISSN: 0193-936X            Impact factor:   6.222


  13 in total

1.  Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer.

Authors:  Anthony R Cillo; Cornelius H L Kürten; Tracy Tabib; Zengbiao Qi; Sayali Onkar; Ting Wang; Angen Liu; Umamaheswar Duvvuri; Seungwon Kim; Ryan J Soose; Steffi Oesterreich; Wei Chen; Robert Lafyatis; Tullia C Bruno; Robert L Ferris; Dario A A Vignali
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

2.  Reducing Cancer Burden in the Population: An Overview of Epidemiologic Evidence to Support Policies, Systems, and Environmental Changes.

Authors:  Elizabeth A Platz
Journal:  Epidemiol Rev       Date:  2017-01-01       Impact factor: 6.222

3.  Association between periodontal disease and oral cancer screening among US adults: NHANES 2011-2014.

Authors:  Shillpa Naavaal; Dina T Garcia; Xiaoyan Deng; Dipankar Bandyopadhyay
Journal:  Community Dent Oral Epidemiol       Date:  2021-05-25       Impact factor: 2.489

4.  Correlation of Betel Quid with Oral Cancer from 1998 to 2017: A Study Based on Bibliometric Analysis.

Authors:  Mu Wang; Chang Xiao; Ping Ni; Jian-Jun Yu; Xiao-Wan Wang; Hong Sun
Journal:  Chin Med J (Engl)       Date:  2018-08-20       Impact factor: 2.628

5.  Disparate survival of late-stage male oropharyngeal cancer in Appalachia.

Authors:  Brenen W Papenberg; Jessica L Allen; Steven M Markwell; Erik T Interval; Phillip A Montague; Christopher J Johnson; Scott A Weed
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

6.  Favorable Lip and Oral Cancer Mortality-to-Incidence Ratios in Countries with High Human Development Index and Expenditures on Health.

Authors:  Wen-Wei Sung; Yong-Chen Hsu; Chen Dong; Ying-Ching Chen; Yu-Chi Chao; Chih-Jung Chen
Journal:  Int J Environ Res Public Health       Date:  2021-06-03       Impact factor: 3.390

7.  Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus.

Authors:  Huanhuan Wang; Qin Zhao; Yuyu Zhang; Qihe Zhang; Zhuangzhuang Zheng; Shiyu Liu; Zijing Liu; Lingbin Meng; Ying Xin; Xin Jiang
Journal:  Front Immunol       Date:  2021-07-08       Impact factor: 7.561

8.  A Taiwanese population-based study on the association between chronic tonsillitis and tonsil cancer.

Authors:  Shih-Han Hung; Li-Ting Kao; Chung-Chien Huang; Ben-Chang Shia; Herng-Ching Lin
Journal:  Oncotarget       Date:  2018-01-17

9.  Targeting FAT1 Inhibits Carcinogenesis, Induces Oxidative Stress and Enhances Cisplatin Sensitivity through Deregulation of LRP5/WNT2/GSS Signaling Axis in Oral Squamous Cell Carcinoma.

Authors:  Tung-Nien Hsu; Chih-Ming Huang; Chin-Sheng Huang; Mao-Suan Huang; Chi-Tai Yeh; Tsu-Yi Chao; Oluwaseun Adebayo Bamodu
Journal:  Cancers (Basel)       Date:  2019-11-27       Impact factor: 6.639

Review 10.  Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck.

Authors:  Qiang Xu; Meiyu Fang; Jing Zhu; Haoru Dong; Jun Cao; Lin Yan; Fransisca Leonard; Felix Oppel; Holger Sudhoff; Andreas M Kaufmann; Andreas E Albers; Xu Qian
Journal:  Int J Biol Sci       Date:  2020-07-19       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.